Services that require precertification
Genetic and genomic tests requiring precertification The following list is a guide to the types of genetic and genomic tests that require precertification.
Download Services that require precertification
Information
Domain:
Source:
Link to this page:
Documents from same domain
HIPAA Transaction Standard Companion Guide
www.ibxtpa.comDecember 2013 • 005010 v1.1 1 Independence Administrators HIPAA Transaction Standard Companion Guide Refers to the Implementation Guides Based on …
BlueCard Worldwide Brochure - IBXTPA
www.ibxtpa.comN20-07-011 Important Call the BlueCard Worldwide Service Center at 1.800.810.BLUE (2583) or call collect at 1.804.673.1177 to locate doctors and hospitals, or obtain medical
AmeriHealth Administrators – iExchange Training
www.ibxtpa.com© 2015 Medecision, Inc. Proprietary and Confidential . Frequently Asked Questions » About iExchange » Aerial™ iExchange® (iExchange) is our
Services that require precertification - ibxtpa
www.ibxtpa.comor “comprehensive” in the name) ANY genetic test that will be billed with a ... • Firmagon (degarelix) • Fulphila (pegfilgrastim-jmdb) ... Direct Ship drug program All drugs on this list require authorization for use of the Direct Ship program.
Related documents
Therapeutic Antibodies for the Treatment of Cancer: Cancer ...
ksbbj.or.krRamucirumab (CYRAMZA ) Extracellular domain of VEGF receptor 2 Inhibit angiogenesis 2014 Fully humanized monoclonal antibody, human IgG1. 110 Korean Society for Biotechnology and Bioengineering Journal 35(2): 105-119 (2020) 2.2. - (Antibody-Drug Conjugate, ADC)
CANCER DRUG PHARMACOLOGY TABLE
www.bccancer.bc.caramucirumab (VEGFR2 and VEGF A, C, and D) regorafenib (VEGFR-1, -2, & -3, TIE2, KIT, RET RAF-1, BRAF, BRAV600E, PDGFR, FGFR) ribociclib (CDK 4/6) rituximab (CD20) ruxolitinib (JAK 1 & 2) sacituzumab govitecan (IgG1.k antibody conjugated with cytotoxic) siltuximab (IL-6) Sonidegib (Hh) sorafinib (c-Raf,b-Raf, V600E,b-Raf,KIT,FLT-3,
Development of therapeutic antibodies for the treatment of ...
jbiomedsci.biomedcentral.comRamucirumab Cyramza Eli Lilly/ImClone Systems Inc. VEGFR2 Human IgG1 Phage display Gastric cancer 2014 Vedolizumab Entyvio Genentech Inc./Millennium Pharmaceuticals Inc./Takeda Pharmaceuticals U.S.A. Inc. α4β7 integrin Humanized IgG1 Hybridoma Ulcerative colitis, Crohn disease 2014 Blinatumomab Blincyto Amgen CD19, CD3 Murine bispecific ...
Procedures, programs and drugs that require …
www.aetna.com(ramucirumab) Danyelza (naxitamab-gqgk) — precertification required effective 3/1/2021 Darzalex (daratumumab) Proprietary . Humatrope* (somatropin) precertification hyaluronidase-oysk) Herzuma (trastuzumab-pkrb) Darzalex Faspro (daratumumab and …
肝臓・胆道・膵臓がん の薬物療法
www.gakkai-net.comREACH-2 2nd* 197 Ramucirumab 4.6% 59.9% 2.8 M 8.5 M 95 Placebo 1.1% 38.9% 1.6 M 7.3 M CELESTIAL 2nd 470 Cabozantinib 4% 64% 5.2 M 10.2 M 237 Placebo 0.4% 33% 1.9 M 8.0 M 分子標的薬に関する主な臨床試験 * AFP ≥ 400 ng/ml
LILLY CARES FOUNDATION Patient Assistance Program …
www.lillycares.comAlimta® (pemetrexed for injection) Cyramza® (ramucirumab) injection Erbitux® (cetuximab) injection Portrazza® (necitumumab) injection Retevmo® (selpercatinib) capsules Verzenio® (abemaciclib) tablets Who qualifies for the Lilly Cares Program? To qualify, you must meet the requirements listed below:
AHFS Pharmacologic-Therapeutic Classification System
www.oregon.govOritavancin (315009) Teicoplanin (379179) Telavancin (310005) Vancomycin (382751) 8:12.28.20 Lincomycins Clindamycin (382399) Lincomycin (382400) 8:12.28.24 Oxazolidinones
Clinical Practice Guidelines in Oncology (NCCN Guidelines ...
www2.tri-kobe.orgBevacizumab, cetuximab, panitumumab, irinotecan, ziv-aflibercept, ramucirumab, regorafenib, trifluridine + tipiracil, nivolumab, or pembrolizumab should not be used in the adjuvant setting for patients with stage II or III colon cancer outside the setting of a clinical trial. COL-4